{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T18:50:45Z","timestamp":1779907845367,"version":"3.53.1"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1097\/nmd.0000000000000093","type":"journal-article","created":{"date-parts":[[2013,12,27]],"date-time":"2013-12-27T08:13:13Z","timestamp":1388131993000},"page":"6-12","source":"Crossref","is-referenced-by-count":10,"title":["Community Adherence to Schizophrenia Treatment and Safety Monitoring Guidelines"],"prefix":"10.1097","volume":"202","author":[{"given":"William R.","family":"Keller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard A.","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"McMahon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Blake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Buchanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R3-3-20210208","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1001\/archpsyc.1982.04290070020005","article-title":"Negative symptoms in schizophrenia: Definition and reliability.","volume":"39","author":"Andreasen","year":"1982","journal-title":"Arch Gen Psychiatry"},{"key":"R4-3-20210208","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1192\/bjp.154.5.672","article-title":"A rating scale for drug-induced akathisia.","volume":"154","author":"Barnes","year":"1989","journal-title":"Br J Psychiatry"},{"key":"R6-3-20210208","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/schbul\/sbp116","article-title":"The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements.","volume":"36","author":"Buchanan","year":"2010","journal-title":"Schizophr Bull"},{"key":"R7-3-20210208","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/oxfordjournals.schbul.a006927","article-title":"The schizophrenia PORT pharmacological treatment recommendations: Conformance and implications for symptoms and functional outcome.","volume":"28","author":"Buchanan","year":"2002","journal-title":"Schizophr Bull"},{"key":"R8-3-20210208","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0165-1781(97)03031-X","article-title":"The Maryland Psychiatric Research Center scale and the characterization of involuntary movements.","volume":"70","author":"Cassady","year":"1997","journal-title":"Psychiatry Res"},{"key":"R9-3-20210208","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1176\/appi.ps.56.3.320","article-title":"Comparison of clozapine use in Maryland and in Victoria, Australia.","volume":"56","author":"Conley","year":"2005","journal-title":"Psychiatr Serv"},{"key":"R11-3-20210208","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1097\/01.mlr.0000215806.11805.6c","article-title":"Associations between adherence to guidelines for antipsychotic dose and health status, side effects, and patient care experiences.","volume":"44","author":"Dickey","year":"2006","journal-title":"Med Care"},{"key":"R12-3-20210208","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/schbul\/sbp115","article-title":"The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements.","volume":"36","author":"Dixon","year":"2010","journal-title":"Schizophr Bull"},{"key":"R13-3-20210208","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1176\/ajp.156.12.1944","article-title":"Repeatable Battery for the Assessment of Neuropsychological Status as a screening test in schizophrenia I: Sensitivity, reliability, and validity.","volume":"156","author":"Gold","year":"1999","journal-title":"Am J Psychiatry"},{"key":"R14-3-20210208","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1023\/B:COMH.0000003015.68850.f2","article-title":"Assessing conformance to medication treatment guidelines for schizophrenia in a community mental health center (CMHC).","volume":"39","author":"Goldman","year":"2003","journal-title":"Community Ment Health J"},{"key":"R15-3-20210208","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1093\/schbul\/10.3.388","article-title":"The Quality of Life Scale: An instrument for rating the schizophrenic deficit syndrome.","volume":"10","author":"Heinrichs","year":"1984","journal-title":"Schizophr Bull"},{"key":"R18-3-20210208","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1503\/jpn.100055","article-title":"Clozapine: A distinct, poorly understood and under-used molecule.","volume":"35","author":"Joober","year":"2010","journal-title":"J Psychiatry Neurosci"},{"key":"R19-3-20210208","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1001\/archpsyc.1983.01790040023003","article-title":"The well-being of chronic mental patients.","volume":"40","author":"Lehman","year":"1983","journal-title":"Arch Gen Psychiatry"},{"key":"R20-3-20210208","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/oxfordjournals.schbul.a007071","article-title":"The schizophrenia Patient Outcomes Research Team (PORT): Updated treatment recommendations 2003.","volume":"30","author":"Lehman","year":"2004","journal-title":"Schizophr Bull"},{"key":"R21-3-20210208","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/oxfordjournals.schbul.a033302","article-title":"Translating research into practice: The Schizophrenia Patient Outcomes Research Team (PORT) treatment recommendations.","volume":"24","author":"Lehman","year":"1998","journal-title":"Schizophr Bull"},{"key":"R22-3-20210208","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1176\/appi.ajp.161.8.1334","article-title":"Physical health monitoring of patients with schizophrenia.","volume":"161","author":"Marder","year":"2004","journal-title":"Am J Psychiatry"},{"key":"R23-3-20210208","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.schres.2005.07.014","article-title":"Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III.","volume":"80","author":"McEvoy","year":"2005","journal-title":"Schizophr Res"},{"key":"R25-3-20210208","doi-asserted-by":"crossref","first-page":"649","DOI":"10.4088\/JCP.v60n1002","article-title":"The Texas Medication Algorithm Project (TMAP) schizophrenia algorithms.","volume":"60","author":"Miller","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"R26-3-20210208","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.schres.2006.06.026","article-title":"Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: Data from the CATIE schizophrenia trial sample at baseline.","volume":"86","author":"Nasrallah","year":"2006","journal-title":"Schizophr Res"},{"key":"R27-3-20210208","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1177\/0269881108100320","article-title":"Psychiatrists attitude towards and knowledge of clozapine treatment.","volume":"24","author":"Nielsen","year":"2010","journal-title":"J Psychopharmacol"},{"key":"R28-3-20210208","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The Brief Psychiatric Rating Scale.","volume":"10","author":"Overall","year":"1962","journal-title":"Psychol Rep"},{"key":"R30-3-20210208","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1001\/archpsyc.56.6.565","article-title":"Cost-effectiveness of clozapine in patients with high and low levels of hospital use. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia.","volume":"56","author":"Rosenheck","year":"1999","journal-title":"Arch Gen Psychiatry"},{"key":"R31-3-20210208","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.312.7023.71","article-title":"Evidence based medicine: What it is and what it isnt.","volume":"312","author":"Sackett","year":"1996","journal-title":"BMJ"},{"key":"R33-3-20210208","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","article-title":"A rating scale for extrapyramidal side effects.","volume":"212","author":"Simpson","year":"1970","journal-title":"Acta Psychiatr Scand"},{"key":"R34-3-20210208","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1177\/0163278708328744","article-title":"Adherence to practice guidelines, clinical outcomes, and costs among Medicaid enrollees with severe mental illnesses.","volume":"32","author":"Stiles","year":"2009","journal-title":"Eval Health Prof"},{"key":"R35-3-20210208","first-page":"CD008298","article-title":"Physical health care monitoring for people with serious mental illness.","volume":"17","author":"Tosh","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"R36-3-20210208","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1600-0447.2007.01016.x","article-title":"Effects of implementation of psychiatric guidelines on provider performance and patient outcome: Systematic review.","volume":"115","author":"Weinmann","year":"2007","journal-title":"Acta Psychiatr Scand"},{"key":"R37-3-20210208","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1176\/appi.ps.56.3.283","article-title":"Patterns and quality of treatment for patients with schizophrenia in routine psychiatric practice.","volume":"56","author":"West","year":"2005","journal-title":"Psychiatr Serv"}],"container-title":["Journal of Nervous & Mental Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/NMD.0000000000000093","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,9]],"date-time":"2023-07-09T09:09:03Z","timestamp":1688893743000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005053-201401000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/nmd.0000000000000093","relation":{},"ISSN":["0022-3018"],"issn-type":[{"value":"0022-3018","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]}}}